Cognitive Behavioral Therapy Aids Patients With Long COVID
By Lori Solomon HealthDay Reporter
MONDAY, Dec. 2, 2024 -- Cognitive behavioral therapy (CBT) and physical and mental health rehabilitation can help improve symptoms of long COVID, according to a review published online Nov. 27 in The BMJ.
Dena Zeraatkar, Ph.D., from McMaster University in Ontario, Canada, and colleagues conducted a systematic literature review to compare the effectiveness of interventions for the management of long COVID (post-COVID condition).
Based on 24 trials (3,695 patients), the researchers found moderate certainty evidence that when compared with usual care, an online program of CBT probably reduces fatigue (mean difference, −8.4) and probably improves concentration (mean difference, −5.2) in patients with long COVID. There was also moderate-certainty evidence that when compared with usual care, an online, supervised, combined physical and mental health rehabilitation program probably leads to improvement in overall health, with an estimated 161 more patients per 1,000 experiencing meaningful improvement or recovery. Moderate-certainty evidence also showed the online, supervised, combined program probably reduces symptoms of depression (mean difference, −1.50) and probably improves quality of life (0.04). Additionally, moderate-certainty evidence showed that intermittent aerobic exercise three to five times weekly for four to six weeks probably improves physical function versus continuous exercise. No compelling evidence was seen to support the effectiveness of vortioxetine, leronlimab, combined probiotics-prebiotics, coenzyme Q10, amygdala and insula retraining, combined L-arginine and vitamin C, inspiratory muscle training, transcranial direct current stimulation, or hyperbaric oxygen.
"We trust that this systematic review will inform future guideline recommendations about the care of patients with long COVID," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Further Support and Information on COVID-19
Read this next
2015 to 2021 Saw Decrease in Incidence of Dementia
FRIDAY, May 23, 2025 -- From 2015 to 2021, there was a decrease in the incidence of dementia, but an increase in prevalence, according to a study published online May 20 in The...
Herpes Simplex Virus Type 1 May Affect Risk for Alzheimer Disease
THURSDAY, May 22, 2025 -- Herpes simplex virus type 1 (HSV-1) is associated with an increased risk for Alzheimer disease (AD) based on real-world data from the United States...
Exposure to Certain HIV Drugs May Significantly Lower Risk for Alzheimer Disease
TUESDAY, May 20, 2025 -- Exposure to nucleoside reverse transcriptase inhibitors (NRTIs), which treat HIV and hepatitis B and inhibit inflammasome activation, is associated with a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.